A meta-analysis on the relationship of eNOS 4b/a polymorphism and diabetic nephropathy susceptibility

Renal Failure

Volumn 36, Issue 10, 2014, Pages 1520-1535

  Zeng, Rong ^a   Duan, Lei ^a   Sun, Lina ^a   Kong, Yuke ^a   Wu, Xiaolu ^a   Wang, Ya ^a   Xin, Gang ^a   Yang, Kehu ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Diabetic nephropathies; Meta analysis; Molecular epidemiology; Nitric oxide synthase type III; Polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

ARTICLE; ASIAN; BIBLIOGRAPHIC DATABASE; CASE CONTROL STUDY; CHINA SCIENCE AND TECHNOLOGY JOURNAL DATABASE; CHINESE BIOMEDICAL DATABASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; EMBASE; EVIDENCE BASED PRACTICE; FULL TEXT DATABASE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MEDLINE; POPULATION RESEARCH; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; WANFANG DATABASE; ETHNOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS;

DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 84908597007     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2014.958955     Document Type: Article

References (59)

1. Ritz E, Rychlk I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999;34(5):795-808
2. Newman DJ, Mattock MB, Dawnay ABS, et al. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess. 2005;9(30):iii-vi, xiii-163
3. Shpichinetsky V, Raz I, Friedlander Y, et al. The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. J Nutr. 2000;130(10): 2493-2497
4. Zintzaras E, Uhlig K, Koukoulis GN, Papathanasiou AA, Stefanidis I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: A meta-Analysis. J Hum Genet. 2007; 52(11):881-890
5. Nakagawa T. Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: An explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol. 2007; 292(6):F1665-F1672
6. Palm F, Teerlink T, Hansell P. Nitric oxide and kidney oxygenation. Curr Opin Nephrol Hypertens. 2009;18(1):68-73
7. Noiri E, Satoh H, Taguchi J-I, et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension. 2002;40(4):535-540
8. Moncada S, Higgs A. The L-Arginine-nitric oxide pathway. N Engl J Med. 1993;329(27):2002-2012
9. Star RA. Intrarenal localization of nitric oxide synthase isoforms and soluble guanylyl cyclase. Clin Exp Pharmacol Physiol. 1997; 24(8):607-610
10. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994;298(Pt 2):249-258
11. Alderton W, Cooper C, Knowles R. Nitric oxide synthases: Structure, function and inhibition. Biochem J. 2001;357:593-615
12. Augeri AL, Tsongalis GJ, Van Heest JL, Maresh CM, Thompson PD, Pescatello LS. The endothelial nitric oxide synthase -786 T4C polymorphism and the exercise-induced blood pressure and nitric oxide responses among men with elevated blood pressure. Atherosclerosis. 2009;204(2):e28-e34
13. Wolff B, Braun C, Schlter C, et al. Endothelial nitric oxide synthase Glu298!Asp polymorphism, carotid atherosclerosis and intimamedia thickness in a general population sample. Clin Sci. 2005;109: 475-481
14. Sinici I, Atalar E, Kepez A, et al Intron 4 VNTR polymorphism of eNOS gene is protective for cardiac syndrome X. J Investig Med. 2010;58(1):23-27
15. Rahimi Z, Shahvaisi-Zadeh F, Sadeghei S, Vessal M, Yavari N. eNOS 4a/b polymorphism and its interaction with eNOS G894T variants in type 2 diabetes mellitus: Modifying the risk of diabetic nephropathy. Dis Markers. 2013;34(6):437-443
16. Santos KG, Crispim D, Canani LH, Ferrugem PT, Gross JL, Roisenberg I. Association of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes. Diabetes Res Clin Pract. 2011;91(3):353-362
17. Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T4C gene variants with diabetic nephropathy. J Diabetes Complications. 2008;22(5):331-338
18. Neugebauer S, Baba T, Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes. 2000; 49(3):500-503
19. Definition, W. H. O. Part 1: Diagnosis and Classification of Diabetes Mellitus. Definition, Diagnosis and Classification of Diabetes Mellzitus and its Complications. Geneva: World Health Organization, Department of Noncommunicable Disease Surveillance; 1999
20. Xue J, Chen LZ, Xue L, Zhou Q. Meta-Analysis of risk factors for childhood cerebral palsy during pregnancy. CJCP. 2013;15(7): 535-540
21. Deeks JJ, Dinnes J, Dámico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):1-173
22. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in metaanalyses. 2010. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed July 2014
23. Yang YL, Liu L, Wang Y, et al. The prevalence of depression and anxiety among Chinese adults with cancer: A systematic review and meta-Analysis. BMC Cancer. 2013;13:393
24. University of Thessaly, School of Medicine Laboratory of Biomathematics. Revealing the Mode of Inheritance in Genetic Association Studies. Available at: http://www.doc88.com/p-579886058890.html. Accessed April 2014
25. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Part 3: Fixed-Effect Versus Random-Effects Models. Introduction to Meta-Analysis. Englewood: Wiley; 2011
26. Alderson P, Creen S, Higgins JPT. Cochrane Reviewer's Handbook4.2.2 (update MSTVH2004). Cochrane Library. Issue 1. Chechester: Wiley; 2004
27. Garn SM. Human Races. Illinois: Thomas; 1971
28. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-Analysis detected by a simple, graphical test. BMJ. 1997;315(7109): 629-634
29. Wang SL. Study of the Susceptibility Genes of Type 2 Diabetic Nephropathy in Northern Chinese. Shandong: Shandong University; 2005
30. Miao L. Association of Nitric Oxide Synthase Gene Polymorphism with Diabetic Nephropathy in Type 2 Diabetic Patients. Shandong: Shandong University; 2003
31. Dong YH, Qu SP, Lü WS, et al. Gene polymorphism in chromosome 7q35 and susceptibility to diabetic nephropathy. Chin J Diabetes. 2005;21(1):47-50
32. Luo H, Ning YY. Association of polymorphism of endothelialnitricoxide synthase gene with diabetic nephropathy. Chin J Diabetes. 2003;11(5):317-320
33. Shestakova M, Vikulova O, Gorashko N, et al. The relationship between genetic and hemodynamic factors in diabetic nephropathy (DN): Case-control study in type 1 diabetes mellitus (T1DM). Diabetes Res Clin Pract. 2006;74(2):S41-S50
34. Li C, Dong Y, Lü W. [The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy]. Zhonghua nei ke za zhi [Chin J Intern Med]. 2001; 40(11):729-732
35. Rippin J, Patel A, Belyaev N, Gill G, Barnett A, Bain S. Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia. 2003;46(3):426-428
36. Mehrab-Mohseni M, Tabatabaei-Malazy O, Hasani-Ranjbar S, et al. Endothelial nitric oxide synthase VNTR (intron 4 a/b) polymorphism association with type 2 diabetes and its chronic complications. Diabetes Res Clin Pract. 2011;91(3):348-352
37. Shoukry A, Shalaby SM, Abdelazim S, et al. Endothelial nitric oxide synthase gene polymorphisms and the risk of diabetic nephropathy in type 2 diabetes mellitus. Genet Test Mol Biomarkers. 2012;16(6):574-579
38. Degen B, Schmidt S, Ritz E. A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy. Nephrol Dial Transplant. 2001;16(1):185-198
39. Shimizu T, Onuma T, Kawamori R, Makita Y, Tomino Y. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract. 2002;58(3): 179-185
40. Ahluwalia TS, Ahuja M, Rai TS, et al. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol Cell Biochem. 2008;314(1-2):9-17
41. Ksiazek P, Wojewoda P, Muc K, Buraczynska M. Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus. Mol Diagn. 2003;7(2):119-123
42. Sun H-Y, Yang M, Liu S, Wang C, Zhang Q, Chen M. Study on the correlation of the polymorphisms of endothelial nitric oxide synthase gene with type 2 diabetes mellitus and diabetic nephropathy. Chin J Prev Contr Chron Non-Commun Dis. 2004; 12(3):101-103
43. Möllsten A, Wessman M, Svensson M, et al. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Ann Med. 2006; 38(7):522-528
44. Fujita H, Narita T, Meguro H, et al. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Horm Metab Res. 2000;32(2):80-83
45. Lin S, Qu HQ, Qiu MC. Study on the association between ecNOS4b/a polymorphism and diabetic nephropathy. Chin J Nephrol. 2002;18(4):258-261
46. Zhang M, Liu H, Yang HY, Wang YM, Song DP, Li H. Relationship of endothelial nitric oxide synthase (eNOS) 4a/b gene polymorphism with diabetic nephropathy. Chin J Diabetes. 2005;11(4):284-285
47. Ma JR. Study on the Relationship between the Endothelial Constitutive Nitric Oxide Synthase (ecNOS) Gene Polymorphism and the Development of Diabetic Vascular Complication in Type 2 Diabetic Patients. Tianjin: Tianjin Medical University; 2003
48. Guo XJ, Liu SJ. The association between endothelial nitric oxide synthase gene polymorphism and type 2 diabetic nephropathy. China Healthc Innovat. 2012;6(19):3-5
49. Xing Q, Su BL, Li CC, et al. Association between endothelial nitric oxide synthase gene polymorphism and type 2 diabetic nephropathy. Chin J Endocrinol Metab. 2004;20(5):435-437
50. Dong J, Zhao J, Lee K, Lir M, Chan S, Liao L. [Distribution of polymorphism in endothelial nitric oxide synthase gene in Singapore Chinese and its association with diabetic nephropathy]. Zhonghua yi xue za zhi. 2007;87(48):3415-3417
51. Turner R, Holman R, Cull C, et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853
52. He Y, Fan Z, Zhang J, et al. Polymorphisms of eNOS gene are associated with diabetic nephropathy: A meta-Analysis. Mutagenesis. 2011;26(2):339-349
53. Nakagawa T, Sato W, Glushakova O, et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol. 2007;18(2):539-550
54. Masuda Y, Shimizu A, Mori T, et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol. 2001;159(2):599-608
55. Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest. 1997;99(11):2625-2634
56. Brodsky SV, Gao S, Li H, Goligorsky MS. Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol Heart Circ Physiol. 2002; 283(5):H2130-H2139
57. Zheng X, Lou J, Yang W. Role of nitric oxide on diabetic nephropathy. Chinese J Nephrol. 1999;2:1-113
58. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-A growing challenge. N Eng J Med. 2007; 356(3):213-215
59. Liu M. Susceptibility Genes, Environmental Risk Factors and their Interactions in the Development of Type 2 Diabetes Mellitus. Wuhan:Huazhong University of Science and Technology; 2006